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Clinical trials have demonstrated that heparan sulfate (HS) could be used as a ther-
apeutic agent for the treatment of inflammatory diseases. Its anti-inflammatory effect 
makes it suitable for the development of biomimetic innovative strategies aiming at 
modulating stem cells behavior toward a pro-regenerative phenotype in case of injury 
or inflammation. Here, we propose collagen type I meshes fabricated by solvent 
casting and further crosslinked with HS (HS-Col) to create a biomimetic environment 
resembling the extracellular matrix of soft tissue. HS-Col meshes were tested for their 
capability to provide physical support to stem cells’ growth, maintain their phenotypes 
and immunosuppressive potential following inflammation. HS-Col effect on stem cells 
was investigated in standard conditions as well as in an inflammatory environment reca-
pitulated in vitro through a mix of pro-inflammatory cytokines (tumor necrosis factor-α 
and interferon-gamma; 20 ng/ml). A significant increase in the production of molecules 
associated with immunosuppression was demonstrated in response to the material 
and when cells were grown in presence of pro-inflammatory stimuli, compared to bare 
collagen membranes (Col), leading to a greater inhibitory potential when mesenchymal 
stem cells were exposed to stimulated peripheral blood mononuclear cells. Our data 
suggest that the presence of HS is able to activate the molecular machinery responsible 
for the release of anti-inflammatory cytokines, potentially leading to a faster resolution of 
inflammation.
Keywords: mesenchymal stem cells, microenvironment, immune response, regeneration, tissue engineering, 
biomolecules, heparan sulfate, collagen
inTrODUcTiOn
Tissues consist of cellular and non-cellular components (Wagers, 2012; Perrini et  al., 2016). 
The extracellular matrix (ECM) represents an intricate network of macromolecules, such as 
water, proteins, and polysaccharides that are produced by the cells and are assembled into an 
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organized network in close association with the cell surface 
(Frantz et  al., 2010). The ECM structure is often remod-
eled, and its molecular components are subjected to 
posttranslational modifications (Burghardt et  al., 2002). 
The production and deposition of these components outside 
the cell surface provide structural and functional integrity 
to connective tissue and organs and act as physical scaffold 
for the cellular constituents. The role of ECM is also crucial 
in the response to growth factors, cytokines, and mechanical 
signals mediated by cell surface receptor, and in the provision 
of biochemical and biomechanical cues that are required for 
tissue morphogenesis, differentiation, and homeostasis (Schultz 
and Wysocki, 2009). Given the ability of ECM to provide bio-
chemical and mechanical properties to any specific tissue (e.g., 
tensile and compressive strength and elasticity), its physical, 
topological, and biochemical composition is tissue specific, but 
largely heterogeneous, and depends on the biochemical and 
biophysical interaction of various cellular components (e.g., 
epithelial, fibroblast, adipocyte, and endothelial elements) and 
the cellular microenvironment (Brizzi et al., 2012). The relative 
amounts of the different types of matrix macromolecules and 
their organization in the ECM reflect the needs of the specific 
host tissue. Among all components of the ECM, glycosami-
noglycans (GAGs) play a series of activities as they influence 
cell proliferation, differentiation, and gene expression (Oohira 
et al., 2000; Lamoureux et al., 2007), modulate protein gradient 
formation and signal transduction (Hacker et  al., 2005). They 
are able to connect ECM structure, retain growth factors, main-
tain chemokines extracellular rate, and prevent growth factors 
degradation. In particular, heparan sulfate (HS) acts as cofactor 
in many biological processes, interacting with diverse protein 
ligands (such as growth factor, viral proteins, enzymes, protease 
inhibitors, and ECM molecules) (Perrimon and Bernfield, 2000; 
Dreyfuss et al., 2009). Furthermore, its activity changes if it is 
linked to the core protein or if it is free. It has been demonstrated 
that HS binds a wide variety of proteins (including chemokines, 
growth factors, morphogens, enzymes, and ECM component) 
that contain basic amino acids with a specific and direct interac-
tion (Lortat-Jacob et al., 1995). HS activity influences cytokines 
processing and consequently their activity (Lortat-Jacob et al., 
1995), while other ligands require some additional sequences to 
explicate their role, such as the interaction between HS and FGF 
receptor (Sasisekharan et al., 1997).
HS applied on mesenchymal stem cells (MSC) biology shows 
its ability to maintain cell growth, proliferation, viability, and 
stemness and decreasing the presence of apoptotic cells. Helledie 
et  al. (2012) have recently evaluated the effect of HS on MSC 
immunophenotype, showing an increase in the expression of 
integrins (CD105 and CD73 molecules), a greater differentiative 
potential, and a more active secretion of molecules that support 
bone repair in an in vivo bone defect.
HS has been also demonstrated to play an important role in 
inflammation, due to its promising anti-inflammatory proper-
ties and the consequent potential to be used as therapeutic 
agent in some type of inflammatory diseases (Li and Vlodavsky, 
2009). Such diseases include, for example, rheumatoid arthritis 
and diabetic nephropathy, where it helps prevent leukocyte 
adhesion and consequently the propagation of inflammation 
(Rops et  al., 2004). Inflammation involves a series of events 
following a tissue injury caused by the presence of harmful 
stimuli, such as infection or physical damage. The first step of 
this reaction is the movement of T  lymphocytes, monocytes, 
and neutrophils from the vascular system to damage site, with 
a cascade of biochemical reactions, which is activated to create 
the appropriate inflammatory response. These biochemical 
reactions increase the levels of chemoattractants, including 
complex components and cytokines, such as tumor necrosis 
factor-α (TNF-α) and interleukin-1β leading to an increased 
expression of the adhesion molecules (e.g., ICAM and VCAM) 
and selectins (Rops et al., 2004).
Therapeutically active MSC have been demonstrated to take 
part in the inflammatory cascade and contribute to tissue homeo-
stasis by releasing trophic factors that act as anti-inflammatory 
immune modulators (Corradetti et al., 2012, 2014, 2016; Lange-
Consiglio et  al., 2016; Perrini et  al., 2016). Their beneficial 
potential can be altered or improved through the exposure to 
bioactive molecules and the development of a naturally inspired 
bioactive material able to support and retain such capability in the 
context of injury or damage is still much needed (Willerth and 
Sakiyama-Elbert, 2008).
In this study, we describe a collagen-based mesh functional-
ized with HS with the aim of modulating inflammation by sup-
porting MSC therapeutic potential. Although different studies 
describe a similar strategy (Meade et  al., 2013; Mothéré et  al., 
2017), the translational point of view was never investigated, 
and the evaluation of the immunosuppressive potential of MSC 
on a bioactive material has never been provided. Figure 1 sum-
marizes the approach we propose. In addition to describe the 
proposed material in terms of topography and stability of its 
functionalization, we evaluated the effect of such meshes to sup-
port the capability of MSC to adhere, proliferate, and maintain 
their conventional features, as well as to actively respond to an 
inflammatory environment, as we previously demonstrated in 
the context of cartilage-resembling materials (Corradetti et  al., 
2016; Taraballi et al., 2016). Using rat bone marrow-derived MSC 
as surrogate local progenitor cells, we investigated the influence 
of our biomimetic natural material in retaining the immunosup-
pressive potential of MSC either in standard conditions or in 
response to the combination of pro-inflammatory cytokines 
[TNF-α and interferon-gamma (IFN-γ)]. The capability of the 
proposed platform to support MSC anti-inflammatory role was 
finally proved in lymphocyte reaction assay.
MaTerials anD MeThODs
Meshes Preparation and characterization
Type I collagen mesh (Col) from bovine tendon (5% collagen 
gel in acetic acid) was produced by a solvent-casting method as 
previously described (Taraballi et al., 2013; Minardi et al., 2016c). 
Briefly, 1 g of type I collagen (Nitta Casings Inc.) was dissolved in an 
acetate buffer (pH 3.5) at the final concentration of 20 mg/ml. The 
collagen suspension was precipitated by the addition of sodium 
hydroxide (0.1  M) solution at pH 5.5. The resulting collagen 
FigUre 1 | Schematic representation of the proposed study.
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slurry was mild crosslinked with 1.5 mM solution of 1,4-butan-
ediol diglycidyl ether (Sigma-Aldrich) for 48 h. The crosslinked 
collagen was washed three times in water, and then the slurry 
was molden in metal racks, at a thickness of 2 mm and air dried 
under a fume hood for 3 days (final thickness: 0.1 mm). Covalent 
functionalization of heparan sulfate (HS) to collagen meshes was 
performed using the coupling reaction with 1-ethyl-3-(3-dimethyl 
aminopropyl)carbodiimide (EDC) and N-hydroxysuccinimide 
(NHS). After weight the collagen matrices, each sample was incu-
bated in a solution of 50 mM 2-morpholinoethane sulfonic acid 
(pH 5.5) in ethanol. After 1 h, the samples were place in a solution 
of 5 mM EDC and 5 mM NHS and 0.2% (w/v) heparan sulfate 
(HS). After reaction for 24  h, the matrices were washed three 
times in PBS. For the stability study, collagen meshes have been 
incubated with the same concentration of HS in the absence of 
crosslinker.
Scanning Electron Microscopy (SEM) Imaging
HS-Col morphology was evaluated by SEM (Quanta 600 FEG, 
FEI Company, Hillsboro, OR, USA). Dried samples were sputter 
coated with 10 nm of Pt/Pd and imaged at a voltage of 10 mA.
Fourier Transform Infrared (FTIR)
Fourier transform infrared spectra were measured in attenu-
ated total reflection using a Nicolet 6700 FT-IR Spectrometer 
(ThermoFisher Scientific). Col and HS-Col meshes were without 
any sample manipulation. Spectra were analyzed by the software 
EZ OMNIC (Nicolet) after baseline correction between 1,800 
and 750 cm−1. The presence of HS was also confirmed by his-
tochemical staining. The meshes were stained by Alcian Blue, 
which labels the proteoglycans.
Enzyme-Linked Lectin Assay (ELLA)
HS crosslinked and absorbed on collagen meshed has been 
incubate in PBS for 14 days at 37°C to evaluate the stability of 
binding between HS and collagen mesh. At each time, point the 
samples were treated with a solution of 2% BSA in PBS (100 µl) 
and shaken (14 h, 5°C). The patches after the blocking step have 
been incubated at room temperature with a solution of WGA 
peroxidase labeled (Sigma-Aldrich) (0.01 mg/ml, 200 µl) in PBS 
for 2 h with shaking. After three washes in PBS, we treated the 
samples with the peroxidase substrate OPD for 1 h. The absorb-
ance was measured at 450 nm in triplicate.
cell cultures
Rat compact bone MSC were isolated as previously reported 
(Corradetti et  al., 2015) and maintained in standard culture 
media represented by Dulbecco’s Modified Eagle’s Medium 
(Sigma) supplemented with 10% fetal bovine serum (Euroclone), 
1% l-glutammine (Gibco), and 1% antibiotic/antimycotic solu-
tion (containing penicillin, streptomycin, and amphotericin B, 
Gibco) at 37°C in a humidified atmosphere with 5% CO2. For 
maintenance of cultures, cells were plated at a cell density of 
5 × 103 cells/cm2. Medium was changed twice per week thereafter 
or according to the experiment requirements. Adherent cells were 
detached and subcultured using TrypLE Express (Invitrogen, 
ThermoFisher Scientific) before reaching confluence (80%) and 
subsequently replated at the same density for culture mainte-
nance (Corradetti et al., 2016). When seeded onto meshes, MSC 
were harvested, resuspended in standard cell culture medium, 
and seeded at the density of 1 × 104 cells/well in 12-well plates 
(Corning). Inserts (Corning) were used to hang membranes 
(Col and HS-Col) and allow for cell adherence onto the col-
lagen without reaching well surface. Standard culture medium 
was then added to each well. Animal studies were conducted 
following approved protocols (AUP-0115-0002) established by 
Houston Methodist Research Institute’s Institutional Animal 
Care and Use Committee in accordance with the guidelines of 
the Animal Welfare Act and the Guide for the Care and Use of 
Laboratory Animals.
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Msc characterization before culture  
onto Meshes
Upon reaching confluence, cells were collected and character-
ized for the expression of MSC-associated markers (CD105, 
CD90, and CD105) with a FortessaTM cell analyzer (Becton 
Dickinson), under the assistance of the HMRI Flow Cytometry 
Core. Antibodies used (APC/Cy7-CD73, PE/Cy7-CD105, and 
Alexa Fluor 700-CD90) were purchased from BioLegend. Briefly, 
MSC were recovered by trypsin method and by spinning down 
at 500  g for 5  min. They were then washed with FACS buffer 
labeled with directly conjugated antibodies according to the 
manufacturer’s indications.
At passage 3, cells were also assessed for their capability to 
undergo osteogenic and chondrogenic differentiation follow-
ing a previously reported procedure (Corradetti et  al., 2015). 
Briefly, to induce osteogenesis, MSC were seeded at the density 
of 5,000  cells/cm2 in 12-well plates. Osteogenic induction was 
performed over 14-day period using a StemPro Osteogenesis 
Differentiation Kit (Gibco). To confirm differentiation, conven-
tional von Kossa was performed. For chondrogenesis, cells were 
seeded at the density of 5,000 cells/cm2. Induction was performed 
using the StemPro Chondrogenesis Differentiation Kit (Gibco) 
for a 14-day period. ECM constituted by proteoglycans was 
visualized by conventional Alcian Blue staining.
effect of Fibroblast-growth Factor (FgF) 
and hs on cell Proliferation
To test the effect of HS in retaining fibroblast-growth factor 
(FGF) and improve cell proliferation, MSC were exposed to 
different conditions, and the growth rate recorded over a 7-day 
period was compared. Conditioned included the following: 
(1) MSC grown in 2D culture systems (CTRL) and treated with 
FGF (10  ng/ml, w/FGF; PeproTech), soluble HS (25  ng/ml, 
w/sHS; Carbosynth), and a combination of both (w/sHS and 
FGF), (2) MSC grown onto Col in presence of soluble HS (Col 
w/sHS), FGF (Col w/FGF), and a combination of the two (Col 
w/sHS and FGF), and (3) MSC grown onto HS-Col in presence 
in presence (HS-Col w/FGF) and absence (HS-Col) of FGF. 
Experiment was set in triplicate. MTT assay (Life Technologies) 
was performed according to the manufacturer’s procedures. 
The concentration of FGF to be used was previously defined in a 
range of 1–100 ng/ml (data not shown).
assessment of Msc Morphology, 
Metabolic activity, and 
immunofluorescence
Mesenchymal stem cells were seeded at the density of 
100,000 cells/cm2 onto HS-Col, Col meshes and cultured for 24 h 
to assess their immediate response to the material in terms of 
proliferation, morphology, adherence, and MSC-associated genes 
expression. Cell proliferation onto membranes was evaluated by 
Alamar Blue (ThermoFisher Scientific) according to manufac-
turer’s instructions during a 3-day period as previously reported 
(Corradetti et al., 2016). Optical density was measured at wave-
lengths of 570 and 600 nm. Data are shown as mean of three inde-
pendent biological replicates. Values have been reported as %AB 
over time, which is associated with the presence of metabolically 
active cells. For comparison, data obtained from MSC grown in 
two-dimensional conditions (CTRL) were also acquired.
Seven days after seeding, cellularized patches and 2D controls 
were washed and fixed in 4% PFA for 20 min. Cell membranes 
were then permeabilized with 0.1% Triton X-100 for 10  min 
and then blocked by 10% goat serum in PBS for 1 h at RT. Cells’ 
actin cytoskeletons were stained with phalloidin (Alexa Fluor 
555, Invitrogen by Life Technologies) and DAPI to identify 
actin cytoskeleton at a dilution of 1/100 in blocking solution at 
RT in darkness, and subsequently the nuclei stained with DAPI 
(ThermoFisher Scientific Inc.) according to the manufacturer’s 
instructions. Samples were imaged with a confocal laser micro-
scope (A1 Nikon Confocal Microscope), and the images were 
analyzed through the NIS-Elements software (Nikon). Col and 
HS-Col sample were imaged by confocal laser microscopy, and 
Z-stacks were acquired.
evaluation of the immunosuppressive 
Potential of Msc grown onto Meshes
To evaluate the efficacy of HS in supporting MSC retain their 
immunosuppressive potential, cells were seeded at the density 
of 100,000  cells/cm2 onto HS-Col, Col meshes and cultured 
for 24  h at 37°C before stimulation with pro-inflammatory 
cytokines occurred. Stimulation was performed as previously 
reported (Hegyi et  al., 2012; Corradetti et  al., 2016). Briefly, 
a combination of rat recombinant IFN-γ and TNF-α (20 ng/ml; 
PeproTech) was used and exposure lasted for 48 and 72 h. Cells 
cultured in 2D conditions (CTRL), whether stimulated (Positive 
CTRL) or not, were used as negative and positive controls, 
respectively. The expression of immunosuppressive markers 
was determined in also on MSC grown onto meshes in absence 
of stimulation. At each time point, the levels of expression of 
genes associated with MSC immunosuppressive potential were 
analyzed as follows.
Peripheral Blood Mononuclear cells 
(PBMc) Proliferation Test
Peripheral blood mononuclear cells were obtained from hep-
arinized whole blood samples using density gradient centrifu-
gation (Lymphoprep; Axis-Shield, Oslo, Norway) following the 
manufacturer’s instructions. PBMC proliferation was induced as 
previously reported (Corradetti et al., 2016). The effect of human 
MSC grown onto meshes (either Col or HS-Col) on T  lym-
phocyte proliferation was determined after 48  h in a cell–cell 
contact setting with MSC and PBMC plated at a 1:10 ratio by 
using CellTrace CFSE Cell Proliferation Kit (Life Technologies). 
Briefly, 24 h after seeding the MSC onto meshes, PBMC were 
stained with CFSE following the manufacturer’s indications and 
cocultured. The percentage of proliferating PBMC in each exper-
imental condition was analyzed by flow cytometry (Millipore).
gene expression analysis
Total RNA was extracted from cells using TRI Reagent® (Sigma) 
and complementary DNA (cDNA) was synthetized from RNA 
TaBle 1 | Oligonucleotide sequences used for quantitative RT-PCR analysis.
gene iD Forward (5′–3′) reverse (5′–3′) length amplified (bp)
 1. Interleukin-6 (Il-6) NM_012589.2 CCTTCCCTACTTCACAAGTCC ACAGTGCATCATCGCTGTTC 179
 2. Tumor necrosis factor-α (Tnf-α) NM_012675.3 GATCGGTCCCAACAAGGAGG GCTTGGTGGTTTGCTACGAC 134
 3. Nitric oxide synthase 2 (iNos) NM_012611.3 GAGCATCCCAAGTACGAGTG AATCTCGGTGCCCATGTACC 140
 4. Prostaglandin E synthase (Pge2) NM_021583.3 ATGAACCCACGCATTCGCTC CTAGAAGGGGCACCAAGTCC 180
 5. Transforming growth factor-beta (Tgf-β) AY550025.1 AGGGCTACCATGCCAACTTC CCACGTAGTAGACGATGGGC 167
 6. Prostaglandin-endoperoxide synthase 2 (Cox-2) NM_017232.3 CTCAGCCATGCAGCAAATCC TCTTGTCAGAAACTCAGGCG 147
 7. Thy-1 cell surface antigen (Cd90) NM_012673.2 GACCCAGGACGGAGCTATTG GCAGTCCAGTCGAAGGTTCT 138
 8. Integrin subunit beta 1 (Cd29) NM_017022.2 CGTGGTTGCCGGAATTGTTC AGTTGTCACGGCACTCTTGT 163
 9. 5′ Nucleotidase, ecto (Cd73) NM_0215762 TCCTGCAAGTGGGTGGAATC CCCCACCGTTGACCAGATAG 170
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using iScript™ cDNA Synthesis Kit (BioRad) according to the 
manufacturer’s protocol. Gene expression analysis was performed 
using specific oligonucleotide primers, designed based on rat 
(Rattus norvegicus) specific sequences and reported in Table 1. 
Pro-inflammatory markers include interleukin-6 (Il-6), Tnf-α, 
and inducible nitric oxide synthase (iNos). Immunosuppression-
associated markers include prostaglandin E2 synthase (Pges2), 
transforming growth factor-beta (Tgf-β), and cyclooxygenase 
(Ptgs2). Mesenchymal-associated markers include Cd90, Cd29, 
and Cd73. Quantitative (real-time) PCR was executed using 
StepOne™ Real-Time PCR System with SYBR® green method. 
The presence of pro-inflammation markers was tested on each 
sample, while immunosuppression-associated markers analysis 
was performed only on non-inflamed samples, at different 
growth conditions. Glyceraldehyde 3-phosphate dehydrogenase 
(Gapdh) was used as reference gene. Each sample was analyzed 
in triplicate.
Differentiation assays were used to establish the plastic 
potential of the cells used in the study as well as to understand 
whether the structural and chemical stimuli provided by the 
meshes could induce cell reprogramming toward two lineages 
of the mesodermic layer. MSC grown in 2D and/or in 3D (Col 
or HS-Col) conditions were harvested following 14  days from 
induction or culture in standard media. RNA was extracted using 
RNeasy mini kit (Qiagen). cDNA was reverse transcribed from 
150 ng of total RNA with iScript retrotranscription kit (BioRad 
Laboratories, Hercules, CA, USA). Amplifications were carried 
on using TaqMan® Fast Advanced Master Mix on a StepOne 
Plus Real-Time PCR System (Applied Biosystems, Foster City, 
CA, USA). The following target probes (Applied Biosystems) 
were applied to evaluate the expression of: osteocalcin (Bglap) 
and alkaline phosphatase (Alp) for osteogenic differentiation. 
Transcription factors Sox-9 (Sox9) and Aggrecan (Acan) were 
evaluated for chondrogenic differentiation. The expression of 
each gene was first normalized to the level of housekeeping gene 
Beta Actin (Actb). Relative fold changes were normalized to the 
respective control. Technical triplicates for each biologic sample 
were evaluated, and results were reported as mean ± SD.
statistical analysis
Statistical analysis was performed by using GraphPad Instat 3.00 
for Windows (GraphPad Software, La Jolla, CA, USA, http://
www.graphpad.com/). Three replicates to evaluate the metabolic 
state of the cells and gene expression were performed. The results 
are reported as mean ± SD, with p < 0.05 used as a threshold 
for significance. One-way analysis of variance for multiple com-
parisons by the Student–Newman–Keuls multiple comparison 
test was used.
resUlTs
Material characterization
Collagen type I from bovine tendon was used for the prepara-
tion of meshes by the solvent-casting method. Since collagen 
contains several free amines groups (32/1,000 amino acid 
residues), we decided to use that as graph point for the dock of 
heparan sulfate (HS) that is characterized by the free carboxyl 
groups to obtain collagen type meshes functionalized with 
HS (HS-Col) (Figure 2A). The topography of the surfaces has 
been analyzed by SEM. Figure 2B shows the topography of the 
HS-Col demonstrating that the crosslink does not affect the 
collagen nanostructure. The presence of HS is confirmed by 
FTIR [Figure 2C shows the averaged (n = 3) of FTIR spectra 
of Col and HS-Col]. Amide I (1,700–1,600  cm−1) and Amide 
II (1,600–1,500 cm−1) are related to the stretching vibration of 
C=O bonds, and C–N stretching and N–H bending vibration 
respectively and are present in both samples, as well as the 
Amide III region (≈1,200–1,300 cm−1). In HS-Col, we found at 
≈1,080 cm−1 (C–O stretching of carbohydrate residues in collagen 
and proteoglycans), ≈845 and ≈1,120 cm−1 (C–O–S stretching), 
and ≈1,397  cm−1 (COO– stretching of amino side chains) 
vibrational modes of GAGs (Corradetti et  al., 2016). We also 
performed a simple Alcian Blue staining to confirm the presence 
of HS on the collagen surface (Figure 2D). After mounting the 
membrane on the insets (Figure 2E), we performed the ELLA. 
Although the presence of HS at the first time point was not sig-
nificant different, the stability of the HS adsorbed is significantly 
lower, in fact after 14 days we lost the half concentration of HS 
onto the surface (Figure 2F).
effect of Fibroblast-growth Factor  
(FgF) and hs on cell Proliferation
After ensuring the cell population was homogeneously positive 
for MSC-associated markers (Figure S1A in Supplementary 
Material) and confirming its differentiative potential toward oste-
ogenic and chondrogenic lineages (Figure S1B in Supplementary 
Material), the efficacy of the proposed HS-Col meshes in acting 
FigUre 2 | Material’s characterization. (a) Structural graft points on collagen ah heparan sulfate to be crosslinked by 1-ethyl-3-(3-dimethyl aminopropyl)
carbodiimide/N-hydroxysuccinimide coupling. (B) Scanning electron microscopy images of HS-Col meshes (scale bar: 5 and 1 μm). (c) Fourier transform infrared/
attenuated total reflection spectra of Col and HS-Col membrane. The green square highlighted the vibrational modes of polysaccharides of HS. (D) Alcian Blue 
staining of Col and HS-Col meshes. (e) Meshes assembled on the inserts to perform the following experiments. (F) Enzyme-linked lectin assay performed at  
0, 7, and 14 days.
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as synthetic ECM and its capability to localize growth factors 
and improve MSC proliferation were assessed in the context of 
FGF over a 7-day period. MTT assay revealed that the presence 
of crosslinked HS allows for the fine control of FGF provided 
to cells (Figure 3). An overall decrease in cell proliferation was 
observed when cells were grown onto 3D structures, both Col 
and HS-Col compared to controls (CTRL), although the group 
HS-Col w/FGF showed a statistically significant (p  <  0.01) 
increase compared to Col w/sHS and FGF at days 3 and 7. 
A block in cell growth was observed in the experimental group 
Col w/sHS and FGF, and no differences were shown between 
MSC grown in standard conditions supplemented with FGF 
(CTRL w/FGF) and a combination of FGF and sHS (CTRL w/
sHS and FGF).
FigUre 3 | MTT assay results at various incubation times (1, 3, and 7 days) using rat mesenchymal stem cells cultured in different experimental conditions: in 
standard 2D culture (CTRL) with soluble HS (w/sHS) or soluble HS and Fibroblast growth factor (w/sHS and FGF), onto collagen-based membranes (Col), with 
soluble HS (Col w/sHS) or soluble HS and Fibroblast growth factor (Col w/sHS and FGF), and onto collagen-based membranes crosslinked with HS (HS-Col)  
and FGF (HS-Col w/FGF). Data are represented as mean of three independent biological replicates ± SD. Bars with different letters depict statistically significant 
differences (p < 0.01).
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cell Viability, Morphology, and spreading
Alamar Blue assay demonstrated that both HS-Col and Col sup-
ported metabolically active cells growth during a period of 3 days 
(Figure 4A). As revealed by optical microscopy after 7 days of 
culture (Figure 4B), MSC spread across the meshes and reached 
confluence, as compared to 2D control (CTRL). Cells grown in 
presence of Col and HS-Col displayed a more spindle-shaped 
morphology compared to CTRL. To compare the cell structures 
formed by MSC adhering to meshes (both Col and HS-Col), 
antibodies to actin was used, and tridimensional images have 
been analyzed at confocal microscope (Figure  4C). Diffused 
cytoplasmic labeling was demonstrated when cells were seeded 
onto Col meshes, together with an intense staining confirming 
similar intracellular cytoskeleton organization. MSC grown onto 
HS-Col displayed a more elongated shape than their Col coun-
terparts and maintained physical contact among them through 
extensions without completely spreading.
Msc-associated Markers expression and 
the Differentiative Potential
Flow cytometry demonstrated a slight reduction in the per-
centage of MSC-associated markers at 3  days compared to 
controls (CTRL) following MSC culture onto HS-Col and Col 
(Figure 4D). To understand the effect of HS-Col on MSC at a 
genetic level, real-time PCR was used to evaluate the expression 
of mesenchymal-associated markers, including Cd29, Cd73, and 
Cd90 (Figure  4E). Molecular analysis showed that at 72  h the 
expression of integrin Cd29 was significantly (p < 0.01) higher 
in cells seeded onto Col than HS-Col and 2D controls (CTRL). 
A statistically significant increase compared to control (CTRL) 
in the expression levels of the same gene was found in HS-Col. 
The expression of Cd73 and Cd90 in cells treated with HS-Col 
was found lower than 2D control (0.475-fold and 0.155-fold, 
respectively). No significant differences were identified for the 
expression of these latter genes in Col.
Being cultured for 14 days onto meshes did not induce any 
increase in the expression of the osteogenesis-associated genes 
tested (Figure S2A in Supplementary Material), although the 
presence of collagen induced a statistically significant increase 
(p < 0.01) in the expression levels of the chondrogenic marker 
Acan compared to the 2D control. For this gene, values were 
assessed around 6.97  ±  1.71 and 10.43  ±  4.23 for Col and 
HS-Col, respectively. The presence of our meshes was associated 
with a great activation of both, osteogenic and chondrogenic 
genes, following 14 days of induction toward the two lineages 
(Figures S2B and S3 in Supplementary Material).
immunosuppressive Potential
To understand whether the exposure of MSC to HS-Col and Col 
could represent a source of stress for the cells, their res ponse to 
the material was tested in absence of any other pro-inflammatory 
molecule. At 48 and 72 h, the levels of expression of genes encod-
ing for immunosuppressive factors (Tnf-α, iNos, and Il-6) were 
evaluated in comparison with untreated cells (CTRL) or inflamed 
cells used as positive controls. Figure 5A shows a great increase 
in the expression of Tnf-α and iNos in cells grown onto HS-Col 
for 48  h compared to CTRL (13.32 ±  0.23 and 19.02 ±  0.15, 
respectively). No significant differences in the expression levels 
of Il-6 were found in Col and HS-Col at the same time point or at 
72 h. Interestingly, the expression of Tnf-α diminished overtime 
in presence of HS, showing lower values than Col (2.11 ± 0.11 vs 
12.24 ± 1.3). The iNos expression was found even increased at 72 h 
FigUre 4 | (a) Alamar Blue assay showing temporal changes (0, 24, and 72 h) in the %AB as representative of the presence of metabolically active cells in Col, 
HS-Col, and mesenchymal stem cells (MSC) grown in 2D conditions (CTRL). Data are shown as mean of three independent biological replicates ± SD. (B) Images 
representing cell morphology at 7 days onto Col, HS-Col, and in 2D conditions (CTRL). 10× magnification, scale bar: 20 µm. (c) Immunofluorescence staining with 
phalloidin (red), DAPI (blue), and vinculin (green) following 24 h culture onto Col and HS-Col. 20× magnification. Scale bars = 10 µm. (D) Histograms showing the 
percentage of CD90+/CD73+ cells at 3 days post HS-Col and Col-treatment. MSC grown in standard conditions a day 0 (CTRL d0) and day 3 (CTRL d3) are 
reported for comparison. (e) Comparison between MSC grown onto Col, HS-Col for the expression of MSC-associated markers (CD29, CD73, and CD90) at mRNA 
level at 24 h in culture. Data are represented as fold change compared with the expression levels found in cells grown in 2D conditions, CTRL (n = 3, **p < 0.01).
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in both Col and HS-Col. Concomitantly, a significant increase in 
the expression of markers mediating the reduction of inflamma-
tion (Tgf-β, Pges2, and Ptgs2) was observed at 48 h in comparison 
with the CTRL and Col, with values assessed around 3.83 ± 0.50 for 
Tgf-β, 4.78 ± 0.50 for Ptgs2, and 57.41 ± 8.60 for Pges2 (Figure 5B). 
Values were found even increased at 72  h in the case of Ptgs2 
and Tgf-β (6.35 ± 0.29 and 9.46 ± 0.38), the same trend being 
observed also for cells exposed to Col. The expression levels of 
Pge2 were found reduced overtime when cells were grown onto 
HS-Col.
To test the efficacy of the proposed material to support MSC 
immunosuppressive potential, cells grown onto Col and HS-Col 
meshes were stimulated with the pro-inflammatory cytokines 
TNF-α and IFN-γ (at the concentration of 20 ng/ml) for 48 and 
72  h. qPCR was used to evaluate the relative amount of genes 
responsible for the production of pro-inflammatory molecules, 
which are responsible for the activation of such process, includ-
ing Tnf-α, iNos, and Il-6. Data were normalized to the respec-
tive untreated control (CTRL, value =  1). Consistent with the 
previous findings, in response to stimulation cells grown onto 
Col produced nearly identical amounts of immunosuppressive 
genes (iNos and Tnf-α) compared with those cultured in 2D and 
standard conditions, whereas cells grown onto HS-Col scaffolds 
produced significantly higher amounts. Figure 6A shows a sig-
nificant increase in the expression of Tnf-α, iNos, and Il-6 in MSC 
grown onto inflamed HS-Col compared to those seeded onto 
inflamed Col at 48 h. Values were assessed around 4.82 ± 1.23, 
6.03 ± 1.46, and 4.24 ± 0.41 for Tnf-a, iNos, and Il-6, respectively. 
FigUre 5 | Comparison between mesenchymal stem cells grown onto Col and HS-Col for the expression of pro-inflammatory (Tnf-α, iNos, and Il-6) (a) and 
anti-inflammatory (Tgf-β, Pge2, and Cox-2) (B) markers at mRNA level after 48 and 72 h. Data are represented as fold change compared with the expression  
levels found in cells grown in 2D conditions, CTRL. Cells treated with a mix of pro-inflammatory cytokines [interferon-gamma and tumor necrosis factor-α (TNF-α and 
IFN-γ, 20 ng/ml)] were used as positive control (Positive CTRL) (n = 3, **p < 0.01).
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At 72 h, a marked decrease in the expression of iNos was found in 
inflamed HS-Col compared to 48 h (6.03 ± 1.46 vs 1.88 ± 0.22), 
which was found even lower than the expression levels found 
in Col at the same time point (2.63 ±  0.52). Finally, when the 
immunosuppressive potential of MSC grown onto HS-Col was 
evaluated in a lymphocyte reaction assay, a marked reduction 
in the proliferation of PHA-stimulated PBMC was noticed after 
2  days of coculture compared to their Col counterparts, with 
percentage of proliferative cells assessed around 44 and 72%, 
respectively (Figure 6B).
DiscUssiOn
Stem cells are widely used in regenerative medicine applications 
because of their properties, particularly their ability to secrete 
bioactive molecules that are known to have an immunosup-
pressive potential and to participate in the recreation of the 
correct pro-regenerative microenvironment following an injury 
(Caplan, 2007). They are closely associated with surrounding 
environment, which is responsible for influencing the way 
they respond to stimuli. The ability of biomaterials mimick-
ing the ECM to promote constructive tissue remodeling can 
be attributed to both their structure and composition. Several 
tissue engineering-based approaches have been developed so 
far in the attempt to recapitulate the composition of the ECM 
(e.g., collagen and GAGs) and provide endogenous cells with the 
physical, chemical, and mechanical stimuli needed to support 
their biological activities during development, homeostasis, 
and response to injury (Corradetti, 2017). We recently devel-
oped collagen-based scaffolds functionalized with chondroitin 
sulfate and demonstrated their capability to induce a cartilage- 
resembling environment able to support stem cell differentia-
tion and immunosuppression, thus holding the promise for the 
treatment of orthopedic chronic diseases (Corradetti et al., 2015, 
2016; Fernandez-Moure et al., 2015; Minardi et al., 2015, 2016a,b; 
Perrini et al., 2016; Taraballi et al., 2016). Among GAGs, also HS 
has been proposed to take part in ECM composition, to retain 
growth factors and chemokines and prevent growth factors 
degradation (Dreyfuss et al., 2009). In the process of developing 
our biomimetic materials for tissue-engineering applications, we 
first tried to understand how HS bioactivity could change when 
provided as soluble molecule, or absorbed/crosslinked onto 
collagen-based membranes. We confirmed that HS influences 
the activity of FGF and actively participates in the presentation 
of the ligand on the receptor improving its activation and conse-
quently cell proliferation (Lortat-Jacob et al., 1995; Sasisekharan 
et al., 1997; Dreyfuss et al., 2009). We also provided evidences 
about the fact that HS supports such activity when crosslinked 
onto collagen-based scaffolds and it is significantly reduced 
when it is in its soluble form or absorbed.
FigUre 6 | Expression at mRNA level of immunosuppression-associated genes (Tnf-α, iNos, and Il-6) of mesenchymal stem cells (MSC) grown onto Col (Inflamed 
Col) and HS-Col (Inflamed HS-Col) following 48 and 72 h stimulation with pro-inflammatory cytokines [interferon-gamma (IFN-γ) and tumor necrosis factor-α (TNF-α), 
20 ng/ml] (a). Data were normalized to the respective untreated control (CTRL, value = 1) (n = 3; **p < 0.01). Cells treated with a mix of pro-inflammatory cytokines 
(IFN-γ and TNF-α, 20 ng/ml) were used as positive control (Positive CTRL). Effect of HS-Col on the proliferation of stimulated peripheral blood mononuclear cells 
(PBMC) after 48 h of coculture with MSC grown onto meshes (B). For comparison, the percentage of stimulated PBMC and resting PBMC is also reported. Data  
are represented as the mean of three biological replicates ± SD. Asterisks depict highly significant (**p < 0.01) and significant (*p < 0.05) differences compared with 
stimulated PBMC.
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We then proposed collagen-based membranes crosslinked 
with heparan sulfate, which mimics the ECM of connective tissues 
to study their effect on MSC proliferation, adhesion, gene expres-
sion, as well as on their potential to release immunosuppressive 
molecules suggested to lead to the resolution of inflammation 
following an injury or an implant.
Biomimetic meshes could be very usefully for the repair of 
different tissues. We recently demonstrated that could be a valid 
alternative to the clinical polymeric materials used in soft tissue 
repair (Minardi et al., 2016c) as well as in cell delivery for more 
regenerative medicine approaches (Pandolfi et al., 2017).
In agreement with the existing literature and with our 
previous observations (Taraballi et  al., 2014, 2016; Minardi 
et  al., 2016a,b), data presented herein show that in presence 
of a 3D culture system cells proliferation appears to be slower 
compared to cells cultured in two-dimensional standard condi-
tions, because of the different growth surface and the need of 
differently reorganizing. This statement supports the apparent 
discrepancies between the metabolic state of the cells and their 
proliferative potential. Our findings are confirmed by the ICC 
analysis revealing that cells grown onto membranes tend to form 
focal adhesion and to create a bond between the synthetic ECM 
and their cytoskeleton (Wozniak et al., 2004). To compare the 
cell adhesion structures formed by MSC adhering to the two 
matrices tested (Col and HS-Col), the presence of different phe-
notype, which are presumably activated through the interaction 
between integrin receptors on cells, was further confirmed by the 
high expression of CD29 (or integrin-β1) at a molecular level, 
72 h after seeding. Our data suggest that MSC are able to create 
a strong connection with the collagen substrate, being the most 
represented protein in ECM (Hynes and Naba, 2012).
These observations were further confirmed by the levels of 
Cd73 and Cd90 expression, as demonstrated by real-time PCR. 
Their expression levels in cells grown within HS-Col were found 
lower than control. Especially, Cd90 appears to be significantly 
down-regulated respect of control. According to these results, 
Ode et  al. (2013) have proved that a downregulation of Cd73 
expression is observed during differentiation, particularly dur-
ing chondrogenesis, and when cells are exposed to mechanical 
stimulation. In other studies it has also been demonstrated that 
a decreasing ability of cells to migrate is associated with a lower 
expression of Cd73 and Cd29, and the reduction of mRNA level 
of Cd90 after mechanical stimulation, as well as during the differ-
entiation (Wiesmann et al., 2006; Ode et al., 2011). Based on this, 
we can speculate that membranes cause a sort of stress in cells 
thus inducing a down regulation of the typical mesenchymal-
associated markers. If this is the case, MSC grown onto HS- 
Col membranes lose their undifferentiated state and the stress 
they undergo could eventually lead their specification toward a 
more committed lineages (Helledie et al., 2012), as suggested by 
the matrix deposition revealed in Figure 4B. We next assessed 
the immunosuppressive potential of these membranes and, at 
the same time, their ability to support the immune-regulatory 
capability attributed to MSC (Caplan and Sorrell, 2015) in 
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response to pro-inflammatory stimuli for their potential use in 
regenerative medicine applications. The first step was to evaluate 
the expression of pro-inflammatory molecules (Tnf-α, iNos, and 
Il-6) at mRNA level, following 48 and 72 h culture onto Col or 
HS-Col, in the attempt to understand whether or not the contact 
with collagen or HS-Col and their topographical properties 
could affect stem cell immunosuppressive behavior. Our data 
demonstrated that high levels of the iNos were produced by cells 
exposed to HS-Col compared to cells grown onto Col or in 2D 
conditions, with values that were found reduced compared to 
other experimental groups at 72 h. To date, these molecules are 
released by MSC to contrast or modulate the activities of several 
immune cell types, included but not limited to T and NK cells 
proliferation, B cell maturation, macrophages polarization, and 
dendritic cell maturation activation. This suggests that the 3D 
environment provided by HS-Col resulted in a greater stress for 
cells, probably due to the different mechanical stimuli that the 
material induces in the cells. Interestingly, however, such activity 
was further stimulated when cells were inflamed with TNF-α 
(20 ng/ml) and IFN-γ (20 ng/ml), leading to a marked accumula-
tion (p < 0.01) of pro-inflammatory molecules, as observed in 
HS-Col compared to Col. These data were corroborated by the 
significant increase in the expression of genes encoding for other 
immunosuppressive molecules, which are normally associated 
with the resolution of inflammation, such as Pges2, Ptgs2, and 
Tgf-β (Zinocker and Vaage, 2012; Zinocker et  al., 2012). To 
further validate the potential of HS-Col meshes to support MSC 
immunosuppression and understand whether the bioactivity of 
the immune modulating molecules produced by MSC following 
stimulation could lead to a reduced T cell proliferation (Zinocker 
and Vaage, 2012; Zinocker et al., 2012), the effect of HS-Col was 
tested in a functional assay. A greater capability to inhibit T cell 
growth was detected when MSC were grown onto meshes (both 
Col and HS-Col) although the presence of HS crosslinked onto 
the collagen membranes was associated with a greater MSC 
immunogenic capability (Corradetti et al., 2016).
cOnclUsiOn
Here, we proposed HS-functionalized biomimetic meshes resem-
bling the composition of ECM of soft tissue. We demonstrated 
that the surface modifications applied on the collagen-based 
material affect MSC behavior and improve their immunosup-
pressive competence. The proposed material represents a proof 
of concept for further developing immunomodulatory materials 
with the capability of supporting and enhancing MSC poten tial, 
and ultimately reducing inflammation at the site of implant.
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FigUre s1 | Mesenchymal stem cells (MSC) characterization. (a) Flow 
cytometric analysis showing MSC are homogeneously positive for CD90, CD73, 
and CD105. (B) Differentiative assay performed on MSC demonstrated they are 
prone to undergo osteogenic and chondrogenic specification. The expression of 
osteoblastogenesis (Alp and Bglap)- and chondrogenesis (Acan and Sox9)-
associated markers was quantified by real-time PCR. Data were normalized to 
the value obtained from uninduced cells (CTRL, value = 1) (n = 3).
FigUre s2 | (a) Effect of HS-Col meshes on the differentiative potential of 
mesenchymal stem cells. Cells grown onto Col and HS-Col were evaluated  
for the expression of osteoblastogenesis (Alp and Bglap)- and chondrogenesis 
(Acan and Sox9)-associated markers at 14 days. Data were normalized to the 
value obtained from cells grown in 2D conditions (CTRL, value = 1) (n = 3).  
(B) Analysis of the same genes following 14 days of induction. Data were 
normalized to the values obtained from the respective uninduced cells (n = 3).
FigUre s3 | Differentiative assays showing the capability of mesenchymal stem 
cells (MSC) to differentiate toward the osteogenic and chondrogenic lineages 
following 14 days of induction. von Kossa and Alamar Blue stainings were used 
to highlight matrix deposition in MSC grown in standard conditions (CTRL) or 
onto Collagen (Col) and heparan sulfate (HS)-functionalized Collagen (HS-Col) 
meshes. Scale bars: 20 μm.
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